Insider Transactions in Q1 2021 at Amarin Corp Plcuk (AMRN)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
John F Thero President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,604
-0.33%
|
$63,624
$6.37 P/Share
|
|
Mar 31
2021
|
John F Thero President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,944
+0.28%
|
-
|
|
Mar 31
2021
|
Joseph T Kennedy General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,803
-1.23%
|
$22,818
$6.37 P/Share
|
|
Mar 31
2021
|
Joseph T Kennedy General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
7,220
+0.78%
|
-
|
|
Mar 31
2021
|
Steven B Ketchum Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,128
-0.71%
|
$18,768
$6.37 P/Share
|
|
Mar 31
2021
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,112
+0.46%
|
-
|
|
Mar 31
2021
|
Michael Wayne Kalb SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,995
-1.55%
|
$17,970
$6.37 P/Share
|
|
Mar 31
2021
|
Michael Wayne Kalb SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,112
+1.05%
|
-
|
|
Mar 31
2021
|
Aaron Berg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,012
-1.04%
|
$18,072
$6.37 P/Share
|
|
Mar 31
2021
|
Aaron Berg President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,112
+0.7%
|
-
|
|
Feb 26
2021
|
John F Thero President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
33,965
-0.53%
|
$203,790
$6.74 P/Share
|
|
Feb 26
2021
|
John F Thero President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
86,311
+0.67%
|
-
|
|
Feb 26
2021
|
Joseph T Kennedy General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
12,404
-2.03%
|
$74,424
$6.74 P/Share
|
|
Feb 26
2021
|
Joseph T Kennedy General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
23,558
+1.86%
|
-
|
|
Feb 26
2021
|
Steven B Ketchum Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,483
-1.3%
|
$68,898
$6.74 P/Share
|
|
Feb 26
2021
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,446
+1.24%
|
-
|
|
Feb 26
2021
|
Michael Wayne Kalb SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,055
-2.89%
|
$66,330
$6.74 P/Share
|
|
Feb 26
2021
|
Michael Wayne Kalb SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,446
+2.77%
|
-
|
|
Feb 26
2021
|
Aaron Berg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,057
-1.92%
|
$66,342
$6.74 P/Share
|
|
Feb 26
2021
|
Aaron Berg President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,446
+1.88%
|
-
|
|
Feb 25
2021
|
John F Thero President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
153,739
-4.7%
|
$1,076,173
$7.3 P/Share
|
|
Feb 25
2021
|
John F Thero President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
390,696
+10.67%
|
-
|
|
Feb 25
2021
|
Joseph T Kennedy General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
55,140
-15.99%
|
$385,980
$7.3 P/Share
|
|
Feb 25
2021
|
Joseph T Kennedy General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
104,728
+23.3%
|
-
|
|
Feb 25
2021
|
Steven B Ketchum Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
45,327
-9.61%
|
$317,289
$7.3 P/Share
|
|
Feb 25
2021
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
88,614
+15.82%
|
-
|
|
Feb 25
2021
|
Michael Wayne Kalb SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
43,395
-19.82%
|
$303,765
$7.3 P/Share
|
|
Feb 25
2021
|
Michael Wayne Kalb SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
88,614
+28.81%
|
-
|
|
Feb 25
2021
|
Aaron Berg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
43,638
-13.82%
|
$305,466
$7.3 P/Share
|
|
Feb 25
2021
|
Aaron Berg President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
88,614
+21.92%
|
-
|
|
Feb 01
2021
|
Steven B Ketchum Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
217,728
-19.12%
|
$1,741,824
$8.05 P/Share
|
|
Feb 01
2021
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
192,358
+9.14%
|
$384,716
$2.65 P/Share
|
|
Jan 29
2021
|
John F Thero President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
82,762
-1.4%
|
$579,334
$7.5 P/Share
|
|
Jan 29
2021
|
John F Thero President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
209,171
+1.74%
|
-
|
|
Jan 29
2021
|
Joseph T Kennedy General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
16,711
-3.31%
|
$116,977
$7.5 P/Share
|
|
Jan 29
2021
|
Joseph T Kennedy General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
42,345
+4.01%
|
-
|
|
Jan 29
2021
|
Michael Wayne Kalb SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,928
-5.28%
|
$104,496
$7.5 P/Share
|
|
Jan 29
2021
|
Michael Wayne Kalb SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
41,789
+6.81%
|
-
|
|
Jan 29
2021
|
Aaron Berg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,281
-1.37%
|
$43,967
$7.5 P/Share
|
|
Jan 29
2021
|
Aaron Berg President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,789
+2.19%
|
-
|
|
Jan 29
2021
|
Steven B Ketchum Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,535
-2.53%
|
$150,745
$7.5 P/Share
|
|
Jan 29
2021
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,789
+2.39%
|
-
|
|
Jan 27
2021
|
Steven B Ketchum Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
421,629
-30.67%
|
$3,373,032
$8.01 P/Share
|
|
Jan 27
2021
|
Steven B Ketchum Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
278,237
+4.75%
|
$556,474
$2.4 P/Share
|